Breast cancer trends in women younger than 40 years in Brazil
- 12 March 2022
- journal article
- research article
- Published by Elsevier in Cancer Epidemiology
- Vol. 78, 102139
Abstract
No abstract availableKeywords
Funding Information
- Pfizer
- Meso Scale Diagnostics
- Roche
- Novartis
- Eli Lilly and Company
- AstraZeneca
This publication has 16 references indexed in Scilit:
- The increasing burden of cancer attributable to high body mass index in BrazilCancer Epidemiology, 2018
- Cancer incidence and mortality among young adults aged 20–39 years worldwide in 2012: a population-based studyThe Lancet Oncology, 2017
- Epidemiology of breast cancer in Indian womenAsia-Pacific Journal of Clinical Oncology, 2017
- The Rise in Mortality from Breast Cancer in Young Women: Trend Analysis in BrazilPLOS ONE, 2017
- Effectiveness of Breast Cancer Screening: Systematic Review and Meta-analysis to Update the 2009 U.S. Preventive Services Task Force RecommendationAnnals of Internal Medicine, 2016
- ACR Appropriateness Criteria Breast Cancer ScreeningJournal of the American College of Radiology, 2013
- Obesity and the Risk for Premenopausal and Postmenopausal Breast CancerCancer Prevention Research, 2012
- Mammographic Density: A Heritable Risk Factor for Breast Cancer2009
- Detection of R337H, a germline TP53 mutation predisposing to multiple cancers, in asymptomatic women participating in a breast cancer screening program in Southern BrazilCancer Letters, 2008
- Cumulative Risk of Breast Cancer to Age 70 Years According to Risk Factor Status: Data from the Nurses' Health StudyAmerican Journal of Epidemiology, 2000